Cardinal Health, Inc. (CAH) Monthly Report
Publication Date: September 22, 2024
Company Overview
Cardinal Health, Inc. (NYSE: CAH) is a leading healthcare services and products company headquartered in Dublin, Ohio. Founded in 1971, Cardinal Health specializes in medical distribution, serving two primary segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company is integral to the healthcare supply chain, providing a wide range of services including the distribution of pharmaceuticals, medical supplies, and comprehensive pharmacy management solutions. Cardinal Health’s product portfolio includes essential items such as surgical gloves, syringes, and radiopharmaceuticals, establishing it as a vital player in the healthcare and finance sectors.
Market Performance and Investment Outlook
In the current medical distribution landscape, the stock is under strong “buy” recommendations. Cardinal Health exhibits sound financial health with total revenues approximating $226.83 billion, paired with a strong investor outlook indicated by a relatively low short interest of 5.25% of the float. As of now, the stock is priced at $111.84, with analysts projecting a target high price of $137.00, reflecting significant potential upside for investors. The mean target price is estimated at $117.41, supporting a favorable investment case with a consensus rating of 2.4 from 15 analysts.
Price Trends and Performance Metrics
Cardinal Health’s stock is currently trading close to its fifty-two week high of $116.05, underscoring its strong performance over the past year. The fifty-day moving average stands at $105.24, suggesting a positive short-term trend. Contrastingly, the fifty-two week low of $85.82 reveals volatility in the stock’s performance, highlighting the fluctuations experienced throughout the year. With its current price showing momentum above the moving average while remaining in proximity to historical peaks, the outlook for Cardinal Health remains promising amid a robust market environment.
In conclusion, Cardinal Health, Inc. represents a compelling investment opportunity within the healthcare sector, meriting close attention from investors looking to capitalize on its potential for sustained growth and profitability.
| Metric | Value |
|---|---|
| Market Cap | $27.1b |
| Total Debt | $5.7b |
| Total Cash | $5.3b |
| Shares Outstanding | 242.0m |
| Float Shares | 242.6m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.